Fulgent Genetics, Inc. — Director's Dealing 2020

Aug 6, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-08-03

Reporting Person: Xie Jian (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	403712	Direct

Footnotes

F1: Reflects 331,212 shares of common stock and 72,500 unvested restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after the vesting commencement date provided in the award agreement granting such restricted stock units, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for issuer on each vesting date.